Guardant Health (NASDAQ:GH) Given New $57.00 Price Target at Scotiabank
Guardant Health (NASDAQ:GH – Free Report) had its target price lifted by Scotiabank from $52.00 to $57.00 in a research note published on Monday,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock. A number of other brokerages have also recently issued reports on GH. UBS Group increased their target price on shares […]
Guardant Health (NASDAQ:GH – Free Report) had its target price lifted by Scotiabank from $52.00 to $57.00 in a research note published on Monday,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock. A number of other brokerages have also recently issued reports on GH. UBS Group increased their target price on shares […]
